about
Epigenetic assays for chemical biology and drug discovery.Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expressionHistone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon MetabolismDevelopment of multiple cell-based assays for the detection of histone H3 Lys27 trimethylation (H3K27me3).MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers.A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes.Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine Methyltransferases.Disruption of Methionine Metabolism in Drosophila melanogaster Impacts Histone Methylation and Results in Loss of Viability.Characterization of the histone methyltransferase PRDM9 using biochemical, biophysical and chemical biology techniques.Epigenetic actions of environmental factors and promising drugs for cancer therapy.S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.Multiplex detection of histone-modifying enzymes by total internal reflection fluorescence-based single-molecule detection.High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2
P2860
Q30358152-9C24DC8C-7A03-4E2B-941F-E6F56906A6B8Q35686336-882AE0BF-9BD8-437B-B4F9-1715C8DE38CEQ36253836-5D1C37BF-6CCF-47CD-A01B-3EEF5A55DCA2Q37184191-FEFBFA73-F635-46AC-BB1E-9EC82A83F723Q37203229-48D78E3D-47A2-4730-9111-68C5BCC286ACQ38673638-D5EF31B8-D89F-4B1F-B135-B44253A0B8A1Q40805420-CD4D8612-4679-4CC9-A719-D99BAAC53C70Q41009749-51E5304A-E0AE-40E9-9F95-BD5404D8177CQ41449642-E3C8C64D-5D1D-4E8B-99CB-055776346B86Q41958381-9202AA10-6DFB-48BA-A8F7-D6B1C5869FE8Q43589467-352E3EE5-2E17-4C06-A446-B55F3E9F3C4DQ49724675-3BCA84DC-C4DB-42CD-964E-2AEEFE192C9AQ50013273-4D3643E2-AC3F-4779-AD6D-C9D78F21DB81Q51629038-CC9F3BBC-4382-4751-A8DF-8D63AC55DDEDQ58977715-7B8CA56A-2016-44FF-9CB1-16E8E9215667
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Assay development for histone methyltransferases.
@ast
Assay development for histone methyltransferases.
@en
type
label
Assay development for histone methyltransferases.
@ast
Assay development for histone methyltransferases.
@en
prefLabel
Assay development for histone methyltransferases.
@ast
Assay development for histone methyltransferases.
@en
P2093
P2860
P356
P1476
Assay development for histone methyltransferases.
@en
P2093
Colin P Walsh
Haiching Ma
Jamie L Planck
Joseph J Ferry
Konrad T Howitz
Kurumi Y Horiuchi
Mia M Eason
Robert F Smith
P2860
P304
P356
10.1089/ADT.2012.480
P577
2013-04-04T00:00:00Z